Tectonic Therapeutic (TECX) Other Operating Expenses (2017 - 2023)
Tectonic Therapeutic's (TECX) quarterly Other Operating Expenses came in at $83.7 million in Q2 2023, up 490.06% on a QoQ basis from $14.2 million in Q4 2017.
Tectonic Therapeutic (TECX) Other Operating Expenses (2017 - 2023) Analysis & Trends
Tectonic Therapeutic (TECX) has 2 years of Other Operating Expenses data on file, last reported at $83.7 million in Q2 2023.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $83.7 million in Q2 2023; TTM through Mar 2024 was $83.7 million, a N/A change from a year earlier, with the FY2023 full-year figure at $83.7 million, changed N/A from the prior year.
- Other Operating Expenses for Q2 2023 stood at $83.7 million, up from $14.2 million in the prior quarter.
- Over the last five years, Other Operating Expenses for TECX reached as high as $83.7 million in Q2 2023 and fell as low as $83.7 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Tectonic Therapeutic | 571.52 Mn | 571.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 83.74 Mn |
| Dec 31, 2017 | 14.19 Mn |